Skip to main content
Caplight Logo









Shanghai OE Biotech Co., Ltd.

Shanghai OE Biotech Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.oebiotech.com/

Last Round

M&A

Aug 30, 2025

Est. Valuation

$181.5M

Total Funding Raised

$15.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Shanghai OE Biotech Co., Ltd. is a biotechnology company that provides multi-omics technology services, including gene sequencing, transcriptomics, proteomics, and metabolomics, to universities, hospitals, and research institutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

multi-omicshigh-throughput sequencingbioinformaticscontract research organizationCROtranscriptomicsproteomicssingle-cell sequencingmetabolomicsgenomicsmass spectrometrybiotech servicesbioinformatics platformprecision medicinedrug discoveryomics data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai OE Biotech Co., Ltd. Comparables

Compare Shanghai OE Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai OE Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Personal Biotechnology Co., Ltd.
90%
Novogene Co. Ltd.
83%
Annoroad Gene Technology
82%

Shanghai OE Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AAug 30, 2025
Series A ExtensionNov 3, 2021
Series AAug 1, 2021
AngelSep 1, 2020

Shanghai OE Biotech Co., Ltd. Investors

Notable investors and investment history

Shanghai OE Biotech Co., Ltd. investors
InvestorRounds
武汉鼎石汇泽投资管理有限公司Series A Extension
健壹资本Series A Extension
Orient Securities Capital Investment CompanySeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 30, 2025

    Closed at $181.5M post-money valuation.

  • Nov 3, 2021

    $16M round led by J-One Capital.

Shanghai OE Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai OE Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai OE Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range55
Year Founded2009
Last FundingAug 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?